A


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
23 07 2020
Historique:
received: 17 02 2020
accepted: 27 05 2020
pubmed: 17 6 2020
medline: 24 8 2021
entrez: 17 6 2020
Statut: epublish

Résumé

Peptide therapeutics, unlike small-molecule drugs, display crucial advantages of target specificity and the ability to block large interacting interfaces, such as those of transcription factors. The transcription co-factor of the Hippo pathway, YAP/Yorkie (Yki), has been implicated in many cancers, and is dependent on its interaction with the DNA-binding TEAD/Sd proteins via a large Ω-loop. In addition, the mammalian vestigial-like (VGLL) proteins, specifically their TONDU domain, competitively inhibit YAP-TEAD interaction, resulting in arrest of tumor growth. Here, we show that overexpression of the TONDU peptide or its oral uptake leads to suppression of Yki-driven intestinal stem cell tumors in the adult

Identifiants

pubmed: 32540914
pii: dmm.044420
doi: 10.1242/dmm.044420
pmc: PMC7390633
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
DNA-Binding Proteins 0
Drosophila Proteins 0
Nuclear Proteins 0
Peptide Fragments 0
Trans-Activators 0
Transcription Factors 0
VGLL1 protein, human 0
YAP-Signaling Proteins 0
Yki protein, Drosophila 0
esg protein, Drosophila 0
sd protein, Drosophila 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust DBT India Alliance
ID : IA/E/13/1/501271
Pays : International
Organisme : Howard Hughes Medical Institute
Pays : United States

Informations de copyright

© 2020. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

Cancers (Basel). 2018 Mar 20;10(3):
pubmed: 29558384
Cell Stem Cell. 2020 May 7;26(5):675-692.e8
pubmed: 32259481
Dev Cell. 2015 Apr 6;33(1):36-46
pubmed: 25850671
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4530-5
pubmed: 24616500
Recent Pat Anticancer Drug Discov. 2017;12(2):148-168
pubmed: 28164756
Cell Metab. 2018 May 01;27(5):1040-1054.e8
pubmed: 29606597
Trends Cancer. 2015 Sep 1;1(1):53-65
pubmed: 26645049
Cell Rep. 2013 Feb 21;3(2):309-18
pubmed: 23395637
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3445-54
pubmed: 23946421
Cell Res. 2014 Mar;24(3):331-43
pubmed: 24458094
Cancer Cell. 2019 Mar 18;35(3):347-367
pubmed: 30889378
J Med Chem. 2018 Jun 28;61(12):5057-5072
pubmed: 29251924
Int J Pharm. 2013 Apr 15;447(1-2):75-93
pubmed: 23428883
Cell. 1986 Aug 15;46(4):575-82
pubmed: 3015419
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):E1312-20
pubmed: 22042863
Cancer Biol Ther. 2013 May;14(5):390-8
pubmed: 23380592
J Biol Chem. 2000 Oct 6;275(40):30801-5
pubmed: 10934189
Cancer Cell. 2017 Apr 10;31(4):532-548.e7
pubmed: 28344039
Nat Genet. 2002 Apr;30(4):367-76
pubmed: 11925563
J Cell Sci. 2009 Jul 15;122(Pt 14):2543-53
pubmed: 19549687
Genes Dev. 2012 Sep 15;26(18):2027-37
pubmed: 22925885
Nature. 2009 Jan 29;457(7229):608-11
pubmed: 19092804
Structure. 2012 Jul 3;20(7):1135-40
pubmed: 22632831
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2163-72
pubmed: 23708122
Cell Rep. 2016 Sep 13;16(11):3062-3074
pubmed: 27626673
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):370-7
pubmed: 22203956
Bioorg Med Chem. 2018 Jun 1;26(10):2700-2707
pubmed: 28720325
J Biol Chem. 1997 Jun 20;272(25):16010-7
pubmed: 9188504
Nature. 2013 Jan 3;493(7430):106-10
pubmed: 23178811
Molecules. 2018 Jun 19;23(6):
pubmed: 29921764
Cancer Cell. 2014 Feb 10;25(2):166-80
pubmed: 24525233
PLoS Biol. 2018 Oct 19;16(10):e3000041
pubmed: 30339698
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2316-2319
pubmed: 31235263
Dev Biol. 2013 May 1;377(1):177-87
pubmed: 23410794
Br J Cancer. 2020 Jan;122(1):4-22
pubmed: 31819192
J Biol Chem. 2007 Mar 23;282(12):8969-77
pubmed: 17227774
Cell Rep. 2012 Jan 26;1(1):13-20
pubmed: 22832104
Theranostics. 2020 Feb 18;10(8):3622-3635
pubmed: 32206112
Development. 1999 Nov;126(22):5161-9
pubmed: 10529432
Dev Biol. 2020 Jan 1;457(1):1-8
pubmed: 31557471
Nat Commun. 2016 Nov 29;7:13615
pubmed: 27897178
Dis Model Mech. 2013 May;6(3):661-78
pubmed: 23324326
Dev Cell. 2019 Jan 28;48(2):277-286.e6
pubmed: 30639055
Cancer Metastasis Rev. 2012 Dec;31(3-4):689-98
pubmed: 22706846
Oncogene. 2009 Apr 30;28(17):1916-27
pubmed: 19330023
Dev Cell. 2008 Mar;14(3):388-98
pubmed: 18258486
Nat Med. 2013 May;19(5):619-25
pubmed: 23584089
Elife. 2014 Apr 22;3:e02181
pubmed: 24755291
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Cancer Cell. 2016 Jun 13;29(6):783-803
pubmed: 27300434
Am J Cancer Res. 2018 Jun 01;8(6):932-943
pubmed: 30034932
Mol Ther. 2007 Feb;15(2):303-9
pubmed: 17235308
Curr Opin Genet Dev. 2016 Oct;40:81-86
pubmed: 27392294
Nat Rev Drug Discov. 2016 Mar;15(3):173-83
pubmed: 26822833
Science. 2013 Nov 8;342(6159):737-40
pubmed: 24114784
Nucleic Acids Res. 2007 Jan;35(Database issue):D247-52
pubmed: 17130144
Nat Rev Drug Discov. 2020 Apr;19(4):277-289
pubmed: 31848464
Development. 1993 Jun;118(2):401-15
pubmed: 8223268
Cell Res. 2013 Oct;23(10):1201-14
pubmed: 23999857
Nature. 2012 Jun 06;486(7401):80-4
pubmed: 22678283
Elife. 2013 Oct 15;2:e00999
pubmed: 24137538
Adv Drug Deliv Rev. 2005 Feb 28;57(4):579-96
pubmed: 15722165
Curr Biol. 2007 Dec 4;17(23):2054-60
pubmed: 17980593
Cells. 2019 Jun 17;8(6):
pubmed: 31212916
Chem Biol. 2011 Aug 26;18(8):1000-10
pubmed: 21867915
Dev Cell. 2013 May 28;25(4):388-401
pubmed: 23725764
Anal Bioanal Chem. 2007 Oct;389(4):1017-31
pubmed: 17668192

Auteurs

Anjali Bajpai (A)

Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India anjalii@iitk.ac.in pradips@iitk.ac.in.

Taushif Ahmad Quazi (TA)

Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Hong-Wen Tang (HW)

Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Nishat Manzar (N)

Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Virender Singh (V)

Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA.

Ashwani Thakur (A)

Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Bushra Ateeq (B)

Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.

Norbert Perrimon (N)

Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
Howard Hughes Medical Institute, Boston, MA 02115, USA.

Pradip Sinha (P)

Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India anjalii@iitk.ac.in pradips@iitk.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH